Skip to content

Proefbevolkingsonderzoek naar de vroege opsporing van hart- en vaatziekten (ROBINSCA)

Risk Or Benefit IN Screening for CArdiovascular Diseases (ROBINSCA)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON24073
Enrollment
39000
Registered
2017-06-30
Start date
2012-12-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary heart disease-related morbidity and mortality

Interventions

intervention 1: screening by means of SCORE intervention 2: screening by means of Coronary Calcium Scoring (CT screening)

Sponsors

ErasmusMC - university medical centre Rotterdam University Medical Centre Groningen Bronovo Hospital The Hague Gelre hospital Apeldoorn
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - age - gender - BMI - waist circumference - family history of CVD

Exclusion criteria

Exclusion criteria: - current CVD - treatment for CVD - no informed consent - use of medication for hypertensie and hypercholesterolemia - CAC scoring last year

Design outcomes

Primary

MeasureTime frame
fatal and non-fatal coronary heart disease

Secondary

MeasureTime frame
extensions of the primary outcome measures

Contacts

Public ContactROBINSCA team
robinsca@erasmusmc.nl0031-10-7030084

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)